The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: Time for reconsideration

Human Reproduction Update

Volumn 10, Issue 6, 2004, Pages 541-548

  Nicolini, Umberto ^a   Lalatta, Faustina ^a   Natacci, Federica ^a   Curcio, Cristina ^a   Bui, The Hung ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytogenetics; Down's syndrome; Genetic counselling; Prenatal diagnosis; QF PCR

Indexed keywords

AGE DISTRIBUTION; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; AUTOMATION; CELL CULTURE; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FETUS CELL; FETUS DISEASE; FLUORESCENCE; HEALTH CARE COST; KARYOTYPE; MATERNAL AGE; MEDICAL DECISION MAKING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME;

ANEUPLOIDY; CHROMOSOME DISORDERS; FEMALE; FETAL DISEASES; FLUORESCENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 8844221276     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/dmh046     Document Type: Article

References (79)

1. Abramsky L and Rodeck CH (1991) Women's choice for fetal chromosome analysis. Prenat Diagn 11,23-29.
2. Abramsky L and Chapple J (1997) 47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of an indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn 17,363-368.
3. Adinolfi M, Pertl B and Sherlock J (1997) Rapid detection of aneuploidies by microsatellite and the quantitative fluorescent polymerase chain reaction. Prenat Diagn 17,1299-1311.
4. Andonova S, Vazharova R, Dimitrova V, Mazneikova V, Toncheva D and Kremensky I (2004) Introduction of the QF-PCR analysis for the puposes of prenatal diagnosis in Bulgaria - estimation of applicability of 6 STR markers on chromosomes 21 and 18. Prenat Diagn 24, 202-208.
5. Association of Clinical Cytogeneticists (1990) National external quality assessment scheme in clinical cytogenetics 1988/89. Association of Clinical Cytogeneticists, UK, pp 9-21.
6. Associazione Italiana di Citogenetica Medica (AICM) (1995) Diagnostica citogenetica. Consensus.
7. Berry AC, Docherty Z and Bobrow M (1992) Abnormal chromosome complement after normal amniocentesis result. Lancet 340, 1361-1362.
8. Bili C, Divane A, Apessos A, Konstantinos T, Apostolos A, Ioannis B, Periklis T and Florentin L (2002) Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR. Prenat Diagn 22,360-365.
9. Brackertz M, Kubbies M and Feige A (1983) Decreased oxygen supply enhances growth in culture of human mid-trimester amniotic fluid cells. Hum Genet 64,334-342.
10. Brambati B and Simoni G (1983) Diagnosis of fetal trisomy 21 in first trimester. Lancet 1,586.
11. Brun JL, Gangbo F, Wen ZQ, Galant K, Taine L, Maugey-Laulom B, Roux D, Mangione R, Horovitz J and Saura R (2004) Prenatal diagnosis and management of sex chromosome aneuploidy: a report on 98 cases. Prenat Diagn 24,213-218.
12. Cheung SW, Crane JP, Johnson A, Simms L and Reid J (1987) A simple method preparing prometaphase chromosomes from amniotic fluid cells. Prenat Diagn 7,383-389.
13. Christian SM, Koehn D, Pillay R, Mac-Dougall A and Wilson RD (2000) Parental decision following prenatal diagnosis of sex chromosomes aneuploidies. J Obstet Gynecol 10,5-7.
14. Cirigliano V, Ejarque M, Canadas M, Paz Lloveras AP, del Mar Perez M, Fuster C and Egozcue J (2001) Clinical Application of multiplex quantitative fluorescent polymerase chain reaction (QF-PCR) for the rapid prenatal detection of common chromosome aneuploidies. Mol Hum Reprod 7,1001-1006.
15. Cirigliano V, Ejarque M, Fuster C and Adinolfi M (2002) X chromosome dosage by quantitative fluorescent PCR and rapid prenatal diagnosis of sex chromosome aneuploidies. Mol Hum Reprod 8,1042-1045.
16. Comas Gabriel C, Galindo A, Martinez JM, Carrera JM, Gutierrez-Larraya F, de la Fuente P, Puerto B and Borrel A (2002) Early prenatal diagnosis of major cardiac anomalies in a high risk population. Prenat Diagn 22, 586-593.
17. Cuckle H (2000) Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92,97-101.
18. Curcio C, Coviello DA, Calderone C, Nicolini U, Kustermann A, Pardi G and Travi M (2004) QF-PCR: a rapid prenatal detection of common chromosomes aneuploidies. Abstracts of European Human Genetics Conference, Munich.
19. Dallapiccola B (2003) Censimento SIGU 2002. Presented at SIGU meeting, Verona,2003
20. Divane A, Carter NP, Spathas DH and Ferguson-Smith MA (1994) Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five-colour fluorescence in situ hybridization. Prenat Diagn 14, 1061-1069.
21. Donague C, Angharad R, Mann K and Ogilvie CM (2003) Development and targeted application of a rapid QF-PCR test for sex chromosome imbalance. Prenat Diagn 23,201-210.
22. Evans MI, Ebrahim SAD, Berry SM, Holzgreve W, Isada NB, Quintero RA and Johnson MP (1994) Fluorescent in situ hybridization utilization for high risk prenatal diagnosis: a trade-off among speed, expense, and inherent limitations of chromosomes specific probes. Am J Obstet Gynecol 171,1055-1057.
23. Ferguson-Smith MA and Yates JRW (1984) Maternal age specific rates for chromosome aberrations and factors influencing them: report of a European collaborative study on 52.965 amniocentesis. Prenat Diagn 4,5-44.
24. Garver KL, Marchese SL and Boas EG (1976) Amniotic fluid culture failure: possible role of syringes. N Engl J Med 295,286-290.
25. Griffiths MJ, Miller PR and Stibbe HM (1996) A false-positive diagnosis of Turner syndrome by amniocentesis. Prenat Diagn 16,463-466.
26. Grimshaw GM, Szczepura A, Hultén M, MacDonald F, Nevin NC, Sutton F and Dhanjal S (2003) Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 7,1-77.
27. Haddow J, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS and Boyd PA (1994) Reducing the need for amniocentesis in women 35 years of age and older with serum markers for screening. N Engl J Med 330, 1114-1118.
28. Harris RA, Washington AE, Nease RF and Kuppermann M (2004) Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 363, 276-782.
29. Hook EB and Chambers GM (1977) Estimated rates of Down syndrome in live births by one year interval for mother aged 20-49 in a New York State study - implications of the risk figures for genetic counselling and cost-benefit analysis of prenatal diagnosis programs. Birth Defects Original Series XIII,123-141.
30. Howe DT, Kilby MD, Sirry H, Barker GM, Roberts E, Davison EV, Mchugo J and Whittle MJ (1996) Structural chromosome anomalies in congenital diaphragmatic hernia. Prenat Diagn 16,1003-1009.
31. Hsu LYF (1992) Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In Milunsky A (ed) Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment. 3rd edn. John Hopkins University Press, Baltimore, pp 155-163.
32. Hultén MA, Dhanjal S and Pertl B (2003) Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction 126,279-297.
33. Jacobs PA (1974) Correlation between euploid structural chromosome rearrangements and mental subnormality in humans. Lancet 249,164-167.
34. Jenderny J, Schmidt W, Hecher K, Hackeloer BJ, Kerber S, Kochhan L and Held KR (2001) Increased nuchal translucency. Hydrops fetalis and Hygroma colli. A new strategy for early fetal aneuploidy detection. Fetal Diagn Ther 16,211-214.
35. Kuo WL, Tenjin H, Segraves R, Pinkel D, Golbus MS and Gray J (1991) Detection of aneuploidy involving chromosomes 13, 18 or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 49,112-119.
36. Kuppermann N, Nease RF, Learman LA, Gates E, Blumberg B and Washington AE (2000) Procedure-related miscarriage and Down-syndrome affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol 96,511-516.
37. Lawce H (1986) Survey of amniotic fluid techniques. Karyogram 12,47-59.
38. Leung WC, Chitayat D, Seaward G, Windrim R, Ryan G, Barrett J and Winsor EJ (2001) Role of amniotic fluid interphase fluorescence in situ hybridization (FISH) analysis in patient management. Prenat Diagn 21,327-332.
39. Leung WC, Lam YH, Wong Y, Lau ET and Tang MHY (2002) The effect of fast reporting by amnio-PCR on axiety levels in women with positive biochemical screening for Down Syndrome - a randomized controlled trial. Prenat Diagn 22,256-259.
40. Leung WC, Lau ET, Lao TT and Tang MH (2003) Can amnio-polymerase chain reaction alone replace conventional cytogenetic study for women with positive biochemical screening for fetal Down syndrome? Obstet Gynecol 101,856-861.
41. Leung WC, Lau ET, Lao TT and Tang MH (2004) Rapid aneuploidy screening (FISH or QF-PCR): the changing scene in prenatal diagnosis? Expert Rev Mol Diagn 4,333-337.
42. Levett LJ, Liddle S and Meredith R (2001) A large scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy. Ultrasound Obstet Gynecol 17,115-118.
43. Lippman A, Tomkins DJ, Shime J and Hamerton JL (1992) Canadian multicentre randomized clinical trial on chorionic villus sampling and amniocentesis. Final report. Prenat Diagn 12,385-408.
44. Mann K, Fox SP, Abbs SJ, Ghing Yau S, Scriven PN, Docherty Z and Ogilvie CM (2001) Development and implementation of a new rapid aneuploid diagnostic service within the UK National Health Service and implication for the future of prenatal diagnosis. Lancet 358,1057-1061.
45. Marteau TM (2002) Prenatal testing: towards realistic expectations of patients, providers and policy makers. Ultrasound Obstet Gynecol 19, 5-6.
46. Marteau TM and Dormandy E (2001) Facilitating informed choice in prenatal testing: how well are we doing? Am J Med Genet 10,185-190.
47. Milunsky A (1998) Genetic Disorders and the Fetus. 4th edn. John Hopkins University Press, Baltimore and London.
48. Niazi M, Coleman DV and Loeffler FE (1981) Trophoblast sampling in early pregnancy culture of rapidly dividine cells from immature placental villi. Br J Obstet Gynecol 88,1081-1087.
49. Nielsen J, Wohlert M and Faaborg-Andersen J (1982) Incidence of chromosome abnormalities in newborn children: comparison between incidence in 1969-1973 and 1980-1982 in the same area. Hum Genet 61,98-104.
50. Ogilvie CM (2003) Prenatal diagnosis for chromosome abnormalities: past, present and future. Path Biol 51,156-160.
51. Paladini D, Russo M, Teodoro A, Pacileo G, Capozzi G, Martinelli P, Nappi C and Calabro R (2002) Prenatal diagnosis of congenital heart disease in the Naples area during the years 1994-1999 the experience of a joint fetal-pediatric cardiology unit. Prenat Diagn 22,545-552.
52. Pertl B, Yau SC, Sherlock J, Davies AF, Mathew CG and Adinolfi M (1994) Rapid molecular method for prenatal detection of Down's syndrome. Lancet 343,1197-1198.
53. Pertl B, Weitgasser U, Fopp S, Kroisel PM, Sherlock J and Adinolfi M (1996) Rapid detection of trisomies 21 and 18 and sexing by quantitative fluorescent multiplex PCR. Hum Genet 98,55-59.
54. Pertl B, Kopp S, Kroisel PM, Tului L, Brambati B and Adinolfi M (1999a) Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet 36,300-303.
55. Pertl B, Pieber D, Lercher-Hartlieb A, Orescovic I, Haeusle M, Winter R, Kroisel P and Adinolfi M (1999b) Rapid prenatal diagnosis of aneuploidy by quantitative fluorescent PCR on fetal samples from mothers at high risk for chromosome disorders. Mol Hum Reprod 5,1176-1179.
56. Petrou S and Mugford M (2004) Should prenatal diagnostic testing be offered to all pregnant women on economic grounds? Lancet 363,258-259.
57. Petticrew MP, Sowden AJ, Lister-Sharp D and Wright K (2000) False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess 4,1-120.
58. Porreco RP, Bradshaw C and Sakar S (1980) Enhanced growth of amniotic fluid cells in the presence of fibroblast growth factor. Obstet Gynecol 55,55-59.
59. Quaife R, Wong LF, Tan SY, Chua WY, Lim SS, Hammersley CJN, Lee HL and Yeo HL (2004) QF-PCR based prenatal detection of aneuploidy in a southeast Asian population. Prenat Diagn 24,407-413.
60. Roberts E, Ely A, Hulten M and Davison EV (1999) The impact of FISH/PCR technology on routine prenatal diagnoss for chromosome abnormality. Cytogenet Cell Genet 85,57-58.
61. Salk D, Disteche C and Stenchever MR (1983) Routine use of Chang medium for prenatal diagnosis improved growth and increased chromosomal breakage. Am J Hum Genet 35,151A.
62. Schmidt W, Jenderny J, Hecher K, Hackeloer BJ, Kerber S, Kochhan L and Held KR (2000) Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reprod 6,855-860.
63. Simoni G, Brambati B, Danesino C, Rossella F, Terzoli GL, Ferrari M and Fraccaro M (1983) Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet 63,349-356.
64. Snijders RJM, Noble P, Sebire N, Souka A and Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352,343-346.
65. Speit G, Haupter S and Pentz S (1990) An improved procedure for the cultivation and in situ chromosome preparation of monolayer cell culture. Cytobios 62,39-47.
66. Spencer JW and Cox DN (1987) Emotional responses of pregnant women to chorionic villi sampling or amniocentesis. Am J Obstet Gynecol 157, 1155-1200.
67. Spencer JW and Cox DN (1988) A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy. Obstet Gynecol 72,714-719.
68. Steele MV and Berg VR, Jr (1966) Chromosome analysis of human amniotic fluid cells. Lancet 1,383.
69. Tabor A, Lind AM and Andersen AM (1984) A culture vessel for amniotic fluid cells allowing faster preparation of chromosome slides. Prenat Diagn 4,451-462.
70. Tepperberg J, Pettenati MJ, Rao PN, Lese CM, Rita D, Wyandt H, Gersen S, White B and Schoonmaker MM (2001) Prenatal diagnosis using interphase fluorescence in situ hybridisation (FISH): two year multicentre retrospective study and review of literature. Prenat Diagn 21,293-301.
71. Valenti C, Schutta EF and Kehaty T (1969) Cytogenetic diagnosis of Down's syndrome in utero. J Am Med Assoc 207,1513.
72. Verma L, Macdonald F, Leedham P, Dhanjal S and Hulten M (1998) Rapid and simple DNA diagnosis of Down's syndrome. Lancet 352, 9-12.
73. Voglino G, Marongiu A, Massobrio M, Campogrande M and Todros T (2002) Rapid prenatal diagnosis of aneuploidies. Lancet 359,442.
74. Von Eggeling F, Freytag M, Fahsold R, Horsthemke B and Claussen U (1993) Rapid detection of trysomy 21 by quantitative PCR. Hum Genet 91,567-570.
75. Warburton D (1982) De novo structural rearrangements: implications for prenatal diagnosis. In AM, Carter TP, and Kelly S (eds) Clinical Genetics: Problems in Diagnosis and Counselling. Academic Press, New York, 63 pp.
76. Warburton D (1984) Outcome of cases of de novo structural rearrangements diagnosed at amniocentesis. Prenat Diagn 4(Special Issue), 69-75.
77. Warburton D (1991) De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am J Hum Genet 49, 995-1013.
78. Wenstrom KD (2003) Aneuploidy screening: the changing scene. Obstet Gynecol 101,840-841.
79. Whiteman DAH and Klinger K (1991) Efficiency of rapid in situ hybridization methods for prenatal diagnosis of chromosome abnormalities causing birth defects. Am J Hum Genet 49 (Suppl),A1279.